These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 18503982)

  • 1. Vascular endothelium as 'novel' target of graft-versus-host disease.
    Tichelli A; Gratwohl A
    Best Pract Res Clin Haematol; 2008 Jun; 21(2):139-48. PubMed ID: 18503982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular endothelium and graft-versus-host disease.
    Biedermann BC
    Best Pract Res Clin Haematol; 2008 Jun; 21(2):129-38. PubMed ID: 18503981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histological evaluation of acute mucocutaneous graft-versus-host disease in nonmyeloablative hematologic stem cell transplants with an observation predicting an increased risk of progression to chronic graft-versus-host disease.
    Bridge AT; Nelson RP; Schwartz JE; Mirowski GW; Billings SD
    Am J Dermatopathol; 2007 Feb; 29(1):1-6. PubMed ID: 17284954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combining altered levels of effector transcripts in circulating T cells with a marker of endothelial injury is specific for active graft-versus-host disease.
    Biedermann BC; Tsakiris DA; Gregor M; Pober JS; Gratwohl A
    Bone Marrow Transplant; 2003 Dec; 32(11):1077-84. PubMed ID: 14625579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interplay of Inflammation and Endothelial Dysfunction in Bone Marrow Transplantation: Focus on Hepatic Veno-Occlusive Disease.
    Vion AC; Rautou PE; Durand F; Boulanger CM; Valla DC
    Semin Thromb Hemost; 2015 Sep; 41(6):629-43. PubMed ID: 26305238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of graft-versus-host disease on skin endothelial and epithelial cell chimerism in stem-cell transplant recipients.
    Willemze AJ; Bakker AC; von dem Borne PA; Bajema IM; Vossen JM
    Transplantation; 2009 Apr; 87(7):1096-101. PubMed ID: 19352133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracranial hemorrhage following allogeneic hematopoietic stem cell transplantation.
    Najima Y; Ohashi K; Miyazawa M; Nakano M; Kobayashi T; Yamashita T; Akiyama H; Sakamaki H
    Am J Hematol; 2009 May; 84(5):298-301. PubMed ID: 19338041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial injury mediated by cytotoxic T lymphocytes and loss of microvessels in chronic graft versus host disease.
    Biedermann BC; Sahner S; Gregor M; Tsakiris DA; Jeanneret C; Pober JS; Gratwohl A
    Lancet; 2002 Jun; 359(9323):2078-83. PubMed ID: 12086762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eczematoid graft-vs-host disease: a novel form of chronic cutaneous graft-vs-host disease and its response to psoralen UV-A therapy.
    Creamer D; Martyn-Simmons CL; Osborne G; Kenyon M; Salisbury JR; Devereux S; Pagliuca A; Ho AY; Mufti GJ; du Vivier AW
    Arch Dermatol; 2007 Sep; 143(9):1157-62. PubMed ID: 17875877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-17-producing T-helper cells as new potential player mediating graft-versus-host disease in patients undergoing allogeneic stem-cell transplantation.
    Dander E; Balduzzi A; Zappa G; Lucchini G; Perseghin P; Andrè V; Todisco E; Rahal D; Migliavacca M; Longoni D; Solinas G; Villa A; Berti E; Mina PD; Parma M; Allavena P; Biagi E; Rovelli A; Biondi A; D'Amico G
    Transplantation; 2009 Dec; 88(11):1261-72. PubMed ID: 19996925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced intensity conditioning for allogeneic hematopoietic stem-cell transplant determines the kinetics of acute graft-versus-host disease.
    Turner BE; Kambouris ME; Sinfield L; Lange J; Burns AM; Lourie R; Atkinson K; Hart DN; Munster DJ; Rice AM
    Transplantation; 2008 Oct; 86(7):968-76. PubMed ID: 18852664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autologous graft-versus-host disease: harnessing anti-tumor immunity through impaired self-tolerance.
    Kline J; Subbiah S; Lazarus HM; van Besien K
    Bone Marrow Transplant; 2008 Mar; 41(6):505-13. PubMed ID: 18026144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein C and procollagen III peptide levels in patients with hepatic dysfunction after allogeneic hematopoietic stem cell transplantation.
    Pihusch M; Wegner H; Goehring P; Salat C; Pihusch V; Andreesen R; Kolb HJ; Holler E; Pihusch R
    Bone Marrow Transplant; 2005 Oct; 36(7):631-7. PubMed ID: 16062176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular endothelial growth factor and activin-a serum levels following allogeneic hematopoietic stem cell transplantation.
    Nachbaur D; Schumacher P; Auberger J; Clausen J; Kircher B
    Biol Blood Marrow Transplant; 2007 Aug; 13(8):942-7. PubMed ID: 17640598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Graft-versus-host disease prophylaxis with everolimus and tacrolimus is associated with a high incidence of sinusoidal obstruction syndrome and microangiopathy: results of the EVTAC trial.
    Platzbecker U; von Bonin M; Goekkurt E; Radke J; Binder M; Kiani A; Stoehlmacher J; Schetelig J; Thiede C; Ehninger G; Bornhäuser M
    Biol Blood Marrow Transplant; 2009 Jan; 15(1):101-8. PubMed ID: 19135948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engraftment syndrome following hematopoietic stem cell transplantation.
    Spitzer TR
    Bone Marrow Transplant; 2001 May; 27(9):893-8. PubMed ID: 11436099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Counting the cost: markers of endothelial damage in hematopoietic stem cell transplantation.
    Woywodt A; Haubitz M; Buchholz S; Hertenstein B
    Bone Marrow Transplant; 2004 Dec; 34(12):1015-23. PubMed ID: 15516935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic graft-versus-host disease presenting as an acute hepatitis after allogeneic peripheral blood stem cell transplantation.
    Fujii N; Takenaka K; Shinagawa K; Ikeda K; Maeda Y; Sunami K; Hiramatsu Y; Matsuo K; Ishimaru F; Niiya K; Yoshino T; Hirabayashi N; Harada M
    Bone Marrow Transplant; 2001 May; 27(9):1007-10. PubMed ID: 11436113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alveolar hemorrhage and acute graft-versus-host disease.
    Ratajczak P; Desveaux A; Socié G; Janin A
    Biol Blood Marrow Transplant; 2007 Oct; 13(10):1244-5. PubMed ID: 17889362
    [No Abstract]   [Full Text] [Related]  

  • 20. Marrow engraftment and clinical manifestations of capillary leak syndrome.
    Cahill RA; Spitzer TR; Mazumder A
    Bone Marrow Transplant; 1996 Jul; 18(1):177-84. PubMed ID: 8832012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.